Clinical Trial Update: Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

View source ↗

Summary

Phase II trial completed for a salivary-based bone loss marker detection platform intended for point-of-care screening of osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Osteoporosis | Status: COMPLETED